[go: up one dir, main page]

ATE235252T1 - Methode zur verminderung arterieller stenose - Google Patents

Methode zur verminderung arterieller stenose

Info

Publication number
ATE235252T1
ATE235252T1 AT95925386T AT95925386T ATE235252T1 AT E235252 T1 ATE235252 T1 AT E235252T1 AT 95925386 T AT95925386 T AT 95925386T AT 95925386 T AT95925386 T AT 95925386T AT E235252 T1 ATE235252 T1 AT E235252T1
Authority
AT
Austria
Prior art keywords
tfpi
arterial stenosis
hours
balloon angioplasty
reducing arterial
Prior art date
Application number
AT95925386T
Other languages
English (en)
Inventor
D Abendschein
Avenue Euclid
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE235252T1 publication Critical patent/ATE235252T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices For Medical Bathing And Washing (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
AT95925386T 1994-07-07 1995-07-06 Methode zur verminderung arterieller stenose ATE235252T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27193094A 1994-07-07 1994-07-07
PCT/US1995/008221 WO1996001649A1 (en) 1994-07-07 1995-07-06 Method of attenuating arterial stenosis

Publications (1)

Publication Number Publication Date
ATE235252T1 true ATE235252T1 (de) 2003-04-15

Family

ID=23037681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95925386T ATE235252T1 (de) 1994-07-07 1995-07-06 Methode zur verminderung arterieller stenose

Country Status (10)

Country Link
EP (1) EP0769962B1 (de)
JP (2) JP4065557B2 (de)
AT (1) ATE235252T1 (de)
AU (1) AU2953795A (de)
CA (1) CA2194443A1 (de)
DE (1) DE69530084T2 (de)
DK (1) DK0769962T3 (de)
ES (1) ES2196067T3 (de)
PT (1) PT769962E (de)
WO (1) WO1996001649A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200506B2 (en) * 1995-06-07 2007-01-18 G.D. Searle Llc Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
ES2285632T3 (es) 1995-06-07 2007-11-16 Novartis Vaccines And Diagnostics, Inc. Formulacion acuosa que comprende tfpi y agentes solubilizadores.
ATE516306T1 (de) 2003-08-13 2011-07-15 Novartis Vaccines & Diagnostic Verbessertes verfahren zur reinigung von tfpi und tfpi-analogen
WO2008114588A1 (ja) * 2007-03-20 2008-09-25 Idemitsu Kosan Co., Ltd. スパッタリングターゲット、酸化物半導体膜及び半導体デバイス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0465557A (ja) * 1990-06-28 1992-03-02 Unitika Ltd 起毛編物の製造方法
EP0473564B1 (de) * 1990-08-27 1996-03-20 Monsanto Company Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
AU4408493A (en) * 1992-06-11 1994-01-04 Washington University Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders

Also Published As

Publication number Publication date
ES2196067T3 (es) 2003-12-16
WO1996001649A1 (en) 1996-01-25
AU2953795A (en) 1996-02-09
JP4065557B2 (ja) 2008-03-26
DE69530084D1 (de) 2003-04-30
DE69530084T2 (de) 2004-02-05
EP0769962A1 (de) 1997-05-02
JPH10502639A (ja) 1998-03-10
PT769962E (pt) 2003-07-31
EP0769962B1 (de) 2003-03-26
DK0769962T3 (da) 2003-06-23
JP2008007512A (ja) 2008-01-17
CA2194443A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
WO1997019679A3 (en) Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis
HUT72317A (en) Use of venflaxine or 3-aryloxi-propaneamine derivatives for preparing pharmaceutical compositions for treatment of incontinence
UA43391C2 (uk) Спосіб інгібування міжклітинного зчеплення і спосіб інгібування запального процесу та порушеного процесу нормальної коагуляції у пацієнтів з розладами васкулярного ендотелію
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
WO1998043618A3 (en) Use of cytoskeletal inhibitors for the prevention of restenosis
BG104316A (en) Tetrazolecontaining analogues of rapamycin, having reduced period of semidecomposition
AU6286294A (en) Guanidine derivatives useful in therapy
ES2131572T3 (es) Compuestos de psoraleno para la inhibicion de la reestenosis consecutiva a la angioplastia.
DE69327263D1 (de) Verwendung des Gewebefaktor-Inhibitors zur Herstellung eines Arzneimittels gegen Mikrogefässthrombose
AU631738B2 (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
LV11728A (lv) Farmaceitiska kompozicija
ATE235252T1 (de) Methode zur verminderung arterieller stenose
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
WO2003045311A3 (en) Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
HU9500857D0 (en) Use of hyaluronic acid and forms to prevent arterial restenosis
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
EP0437025A3 (en) Compositions containing aldose reductase inhibitors for the treatment of ulcers
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
AU7921698A (en) Use of phospholamban inhibitors for increasing coronary flow

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0769962

Country of ref document: EP

REN Ceased due to non-payment of the annual fee